Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 29:9:971879.
doi: 10.3389/fnut.2022.971879. eCollection 2022.

Inverse association of serum carotenoid levels with prevalence of hypertension in the general adult population

Affiliations

Inverse association of serum carotenoid levels with prevalence of hypertension in the general adult population

Xu Zhu et al. Front Nutr. .

Abstract

Carotenoid levels are inversely associated with blood pressure (BP). This study focused on the effects of individual and combined serum carotenoids on BP and hypertension, which have not been established to date. Data from National Health and Nutrition Examination Survey (NHANES) 2001-2006 were analyzed in this cross-sectional study. Multivariate logistic, linear, and weighted quantile sum (WQS) regression analyses were applied to explore the associations of six serum carotenoids (α-carotene, β-cryptoxanthin, lutein/zeaxanthin, trans-lycopene, trans-β-carotene, and cis-β-carotene), individually and in combination, with BP/hypertension. The linearity of correlations was further assessed using restricted cubic spline (RCS) regression. A total of 11,336 adults were included for analysis. Data from multivariate models showed that all six carotenoids were independently and negatively associated with both systolic blood pressure (SBP) and diastolic blood pressure (DBP; all p < 0.05). Compared to the first quartile, the fourth quartile of α-carotene (odds ratio [OR] = 0.64 [0.52-0.77]), β-cryptoxanthin (OR = 0.74 [0.60-0.90]), trans-β-carotene (OR = 0.50 [0.40-0.61]), and cis-β-carotene (OR = 0.47 [0.35-0.64]) were significantly and inversely related to hypertension (all p < 0.05). Moreover, WQS analysis revealed that the combination of all six serum carotenoids was negatively associated with BP and hypertension (all P<0.001), among which trans-β-carotene was the most significant contributor to the protective effect against hypertension (weight, 59.50%). Dose-response analyses demonstrated a linear inverse association of all carotenoids with hypertension (p for non-linearity > 0.05). Our collective findings indicate that higher levels of all six mixed serum carotenoids are correlated with decreased prevalence of hypertension, among which β-carotene exerts the most significant effect, which may provide a basis and direction for further studies.

Keywords: NHANES; WQS; blood pressure; hypertension; serum carotenoids.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Weights from weighted quantile sum regression (WQS) for the mixture of six serum carotenoids in relation to hypertension-related outcomes. Models are adjusted for age, sex, education level, race, poverty, smoker, alcohol user, physical activity, energy intake level, body mass index, hemoglobin, total cholesterol, high-density lipoprotein cholesterol, eGFR, and diabetes.
FIGURE 2
FIGURE 2
Restricted cubic spline (RCS) analysis with multivariate-adjusted associations between six serum carotenoids and prevalence of hypertension (SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg) in adults. Models are adjusted for age, sex, education level, race, poverty, smoker, alcohol user, physical activity, energy intake level, body mass index, hemoglobin, total cholesterol, high-density lipoprotein cholesterol, eGFR, and diabetes.

Similar articles

Cited by

References

    1. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension global hypertension practice guidelines. J Hypertens. (2020) 38:982–1004. 10.1097/HJH.0000000000002453 - DOI - PubMed
    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. (2005) 365:217–23. - PubMed
    1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. (2020) 16:223–37. 10.1038/s41581-019-0244-2 - DOI - PMC - PubMed
    1. Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res. (2021) 128:993–1020. 10.1161/CIRCRESAHA.121.318063 - DOI - PMC - PubMed
    1. Tran N, Garcia T, Aniqa M, Ali S, Ally A, Nauli SM. Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: In physiology and in disease states. Am J Biomed Sci Res. (2022) 15:153–77. - PMC - PubMed

LinkOut - more resources